These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 481381)

  • 1. [Efficacy of chemo-hormonotherapy on the incidence of recurrence in resectable bladder carcinoma].
    Bernardo G; Fantoni S; Colloi D; Cuzzoni Q; Vicini D; Robustelli Della Cuna G
    Minerva Urol; 1979; 31(2):113-8. PubMed ID: 481381
    [No Abstract]   [Full Text] [Related]  

  • 2. New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.
    van der Meijden AP
    Prog Clin Biol Res; 1992; 378():95-101. PubMed ID: 1301591
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of intravesical chemotherapy and possibilities for improving its efficacy.
    Sylvester RJ
    Eur Urol; 2006 Aug; 50(2):233. PubMed ID: 18219714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Low-grade, low-stage transitional carcinoma of the bladder. Analysis of 147 cases].
    Escudero Barrilero A; Gutiérrez Sanz-Gadea C; Hernández Fernández C; Mateos Torres A; Maganto Pavón E; Mayayo Dehesa T
    Actas Urol Esp; 1985; 9(2):135-46. PubMed ID: 3925729
    [No Abstract]   [Full Text] [Related]  

  • 5. [Local chemotherapy in vesical neoplasms].
    Pavone-Macaluso M; Caramia G; Rizzo FP
    J Radiol Electrol Med Nucl; 1974 Nov; 55(11):844-8. PubMed ID: 4217830
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravesical chemotherapy for carcinoma of the bladder--duration of the treatment course.
    Jakse G
    Prog Clin Biol Res; 1985; 185B():69-78. PubMed ID: 3898142
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and experimental projects on chemotherapy of bladder tumours.
    Pavone-Macaluso M; Rausa L; Gebbia N; Caramia G; Rizzo FP; Arena E; Tessitore V; Vecchioni M
    S Afr Med J; 1974 Mar; 48(15):631-6. PubMed ID: 4378338
    [No Abstract]   [Full Text] [Related]  

  • 8. [Systemic chemotherapy of bladder cancer].
    Seematter RJ
    Helv Chir Acta; 1982 Aug; 49(3-4):339-43. PubMed ID: 6890050
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy of bladder cancer: a review.
    Smith PH
    Cancer Treat Rep; 1981; 65 Suppl 1():165-73. PubMed ID: 6799197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical treatment of urothelial tumors of the bladder].
    Ferrière JP; Dionet C; Dauplat J; Boiteux JP; Plagne R; Giraud B
    Ann Urol (Paris); 1988; 22(4):229-34. PubMed ID: 3056230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors.
    Colombo R
    Eur Urol; 2006 Aug; 50(2):233-4. PubMed ID: 18219715
    [No Abstract]   [Full Text] [Related]  

  • 12. What matters - early start or duration of chemotherapy instillation regimens or patient characteristics?
    Kaasinen E
    Eur Urol; 2008 May; 53(5):882-5; discussion 885-6. PubMed ID: 18262339
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
    García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; González Alvarez RC; Jalón Monzón A; Martínez Gómez FJ; Sánchez Trilla A; Regadera Sejas J
    Arch Esp Urol; 2007; 60(1):36-43. PubMed ID: 17408170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Directed chemotherapy in superficial carcinoma conditioned by the knowledge of relapse factors].
    Oliver F; Llopis B; Vera C; Domínguez C; Vidal J; Gallego J; Jiménez JF
    Actas Urol Esp; 1988; 12(5):419-23. PubMed ID: 3218579
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trial chemotherapy in the treatment of bladder cancers].
    Le Duc A; Camey M
    J Urol Nephrol (Paris); 1974; 80(7-8):684-8. PubMed ID: 4444069
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given?
    Bouffioux C
    Prog Clin Biol Res; 1985; 185B():47-55. PubMed ID: 4034591
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrency rate influencing effect on intravesical Lycurim treatment in transurethrally resected bladder tumours.
    Kondás J; Szentgyörgyi E
    Ther Hung; 1983; 31(2):55-8. PubMed ID: 6571182
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials.
    Stewart AB; Mostafid H
    J Urol; 2005 Apr; 173(4):1433; author reply 1433. PubMed ID: 15758827
    [No Abstract]   [Full Text] [Related]  

  • 19. The place of intravesical chemotherapy as defined by results of prospective randomized studies (substances and treatment schemes).
    Lamm DL; Griffith JG
    Prog Clin Biol Res; 1992; 378():43-53. PubMed ID: 1301585
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin].
    Llopis B; Sánchez A; Boronat F; Gallego J; Moreno B; Alonso M; Martínez R; Vera CD; Jiménez JF
    Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.